Nearsightedness in children is increasing at a rate that has captured the attention of eye care professionals worldwide. According to the National Eye Institute, 42 percent of Americans are now nearsighted, nearly double the 25 percent rate measured in the early 1970s. This increase is driven by changes in how children spend their time, with more hours devoted to close-up activities and less time spent outdoors. For parents, understanding what myopia management is and why it matters has become an essential part of protecting their child's long-term eye health.
Myopia is not simply a matter of needing glasses. Higher levels of nearsightedness are associated with increased risk of sight-threatening conditions later in life, including retinal detachment, glaucoma, and myopic macular degeneration. According to a peer-reviewed analysis, slowing nearsightedness by just one diopter reduces the lifetime risk of macular degeneration by 40 percent. That single statistic illustrates why managing myopia during childhood, when the eye is still growing, can have lasting benefits.
Myopia management refers to a set of clinical treatments designed to slow the rate at which a child's nearsightedness worsens over time. It does not eliminate myopia or reverse the existing prescription. Instead, it reduces how much additional myopia develops during the growth years, aiming for a lower final prescription by adulthood. Think of it as managing the pace of a process that is already in motion, rather than trying to stop it entirely.
Myopia occurs when the eyeball grows too long from front to back. Light entering the eye focuses in front of the retina instead of directly on it, causing distant objects to appear blurry. During childhood and adolescence, the eye is still growing, and in nearsighted children, this growth outpaces what is needed for clear vision. The longer the eye becomes, the stronger the prescription required to correct the blur.
The rate of myopia progression varies significantly among children. Key factors include the age at which myopia first appears, with younger onset typically leading to faster progression. Family history plays a role as well, as children with nearsighted parents are at higher risk. Environmental factors such as limited outdoor time and extensive near work contribute to faster progression. Your eye doctor evaluates all of these factors when designing a management plan tailored to your child.
Myopia has both genetic and environmental components. A child with two nearsighted parents has a significantly higher risk of developing myopia than a child with no family history. However, the rapid increase in myopia rates over recent decades cannot be explained by genetics alone, since the human gene pool does not change that quickly. Environmental factors, particularly reduced outdoor exposure and increased time spent on close-up tasks, are major contributors to the current trend.
Ortho-K involves wearing specially designed rigid lenses overnight that gently reshape the cornea during sleep. The child removes the lenses in the morning and sees clearly without correction all day. In addition to vision correction, ortho-K has been shown to slow myopia progression by altering the peripheral focus pattern on the retina. This dual benefit makes it one of the most popular myopia management options for children and families.
Low-dose atropine drops are administered once daily at bedtime and work by slowing the signaling pathways that drive eye elongation. The treatment is simple and well suited for younger children who are not yet ready for contact lenses. Clinical trials lasting up to five years have shown that low-dose atropine can slow progression by more than half, with minimal side effects at the concentrations typically prescribed.
Multifocal soft contact lenses and specialty spectacle lenses designed for myopia control use advanced optical designs that create peripheral defocus on the retina. This peripheral signal may help slow eye growth while providing clear central vision for daily activities. These options are suitable for children who are comfortable with contact lens wear or who prefer a glasses-based approach. Both have shown meaningful slowing effects in clinical studies.
Specialty spectacle lenses are particularly appealing for younger children or those who are not ready for contact lenses. They look and feel like regular glasses, with the myopia-slowing technology built into the lens design. Daily disposable multifocal contacts are a good option for older children who want the freedom of contact lens wear combined with myopia management benefits. Your eye doctor can help determine which option fits your child's lifestyle and maturity level.
At Insight Vision Optometry, Las Vegas, the myopia management process begins with a comprehensive evaluation that includes refraction, corneal topography, and axial length measurement. Your eye doctor assesses your child's current prescription, rate of progression, family history, and visual habits. This information guides the treatment recommendation and establishes a baseline for tracking improvement over time.
The choice of treatment depends on your child's age, maturity, lifestyle, and the severity of their myopia. Your eye doctor will present the options that are most appropriate for your child and explain the benefits and practical considerations of each. The decision is collaborative, and families from Henderson, Enterprise, Paradise, Spring Valley, and throughout the Las Vegas area work with our team to find the approach that fits best.
Once treatment begins, your child returns for regular follow-up visits every three to six months. At each visit, your eye doctor remeasures the prescription and axial length to track whether the treatment is effectively slowing progression. If the current approach is working well, it continues unchanged. If progression is faster than expected, the treatment plan may be adjusted by modifying the dose, changing the approach, or adding a complementary treatment for a stronger combined effect.
Treatment can begin as soon as myopia is diagnosed and confirmed to be progressing. Children as young as four or five can start with atropine drops or specialty spectacle lenses. Contact lens options typically become available around age eight, depending on the child's maturity. The earlier treatment starts, the more years of active progression it can slow, which may result in a meaningfully lower final prescription.
Myopia management slows the rate of progression but does not stop it completely. Most children on treatment still experience some increase in their prescription over time, just at a slower rate than they would without treatment. The goal is to reduce the total amount of myopia that develops, which lowers the risk of associated eye conditions in adulthood.
Yes, in most cases. Myopia management treatments do not eliminate the existing prescription. Children using atropine drops continue wearing their current glasses or contact lenses. Children on ortho-K wear the reshaping lenses at night and see clearly during the day without correction. Children using specialty spectacle lenses or multifocal contacts wear them as their primary vision correction throughout the day.
Your eye doctor tracks two key measurements at each follow-up visit: the refraction, which shows the prescription, and the axial length, which measures the physical length of the eye. A slower rate of change in these measurements compared to the expected untreated progression indicates that the treatment is working. Your eye doctor will share these results with you and explain what they mean for your child's long-term outlook.
A typical follow-up visit takes 20 to 30 minutes and includes vision testing, refraction, axial length measurement, and a discussion of your child's progress. The initial evaluation may take longer because it includes a comprehensive eye exam and corneal mapping. Your eye doctor will explain the results at each visit so you can see how the treatment is performing and participate in any decisions about adjustments to the plan.
Yes. Multiple large studies have shown that children who spend more time outdoors are less likely to develop myopia and tend to have slower progression if already nearsighted. The protective effect is believed to be related to the intensity of natural outdoor light. Aiming for at least two hours of outdoor time per day is a practical, no-cost strategy that complements clinical treatment. In the Las Vegas area, where sunshine is available most of the year, outdoor time is especially accessible.
When myopia management treatment is stopped, progression may resume at its natural rate. In some cases, a brief rebound acceleration has been observed, particularly with atropine drops that are discontinued abruptly rather than tapered gradually. Treatment is typically continued throughout the active growth years, and your eye doctor will recommend a gradual tapering schedule when the time comes to discontinue. The decision to stop is based on your child's age, current rate of progression, and overall eye health.
Yes. Combination therapy, such as ortho-K with low-dose atropine or specialty lenses with atropine, is sometimes recommended for children with particularly rapid progression or insufficient response to a single treatment. Combining treatments that work through different mechanisms can provide a stronger overall slowing effect. Your eye doctor will determine whether combination therapy is appropriate based on your child's individual response and progression pattern.
